BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:38 PM
Oct 05, 2012
 |  BC Extra  |  Company News

GSK returns rights to Anacor antibiotic

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) will return to Anacor Pharmaceuticals Inc. (NASDAQ:ANAC) all rights for antibiotic GSK2251052. In February, GSK suspended enrollment in all trials of GSK2251052 following a microbiological finding of...

Read the full 149 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >